Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ARWR
ARWR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ARWR News
Arrowhead's Plozasiran Significantly Reduces TG Levels in Hypertriglyceridemia Patients
2d ago
Newsfilter
Ionis Pharmaceuticals Lowers Tryngolza Price to Enhance Competitive Positioning
4d ago
Newsfilter
WVE-007 Trial Data Triggers Stock Volatility
4d ago
stocktwits
Johnson & Johnson Divests from 3 Biotech Companies While Retaining Investments in Potential Acquisition Candidates
5d ago
Barron's
AvaíBio Initiates α-Klotho Cell Bank Creation
6d ago
PRnewswire
AvaíBio Initiates Master Cell Bank for α-Klotho Production
6d ago
Newsfilter
CRISPR Therapeutics Shares Surge on Strong Earnings and Pipeline Growth
Feb 26 2026
Benzinga
Arrowhead Pharmaceuticals to Participate in Multiple Upcoming Conferences
Feb 24 2026
Newsfilter
Morgan Stanley Lowers Arrowhead Price Target to $78
Feb 18 2026
Yahoo Finance
Strategic Shift in Biotech Dealmaking
Feb 17 2026
Globenewswire
Strategic Shift in Biopharma Dealmaking
Feb 17 2026
Newsfilter
Casgevy Therapy Revenue Shows Significant Growth
Feb 13 2026
Benzinga
Arrowhead Pharmaceuticals Q1 2026 Earnings Call Highlights
Feb 06 2026
seekingalpha
Arrowhead Pharmaceuticals Q1 Earnings Exceed Expectations
Feb 05 2026
seekingalpha
Arrowhead Pharmaceuticals Set to Announce Q1 Earnings on February 5th
Feb 04 2026
seekingalpha
Privium Fund Management Reduces Arrowhead Holdings
Feb 03 2026
Fool
Show More News
